IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLES

Bilirubin (total And Unbound) In The Neonate Test System

INSTRUMENTATION LABORATORY CO.

The following data is part of a premarket notification filed by Instrumentation Laboratory Co. with the FDA for Il Synthesis--addition Of Bilirubin As A Measured Parameter For Neonate Whole Blood Samples.

Pre-market Notification Details

Device IDK980646
510k NumberK980646
Device Name:IL SYNTHESIS--ADDITION OF BILIRUBIN AS A MEASURED PARAMETER FOR NEONATE WHOLE BLOOD SAMPLES
ClassificationBilirubin (total And Unbound) In The Neonate Test System
Applicant INSTRUMENTATION LABORATORY CO. 113 HARTWELL AVE. Lexington,  MA  02173
ContactCarol Marble
CorrespondentCarol Marble
INSTRUMENTATION LABORATORY CO. 113 HARTWELL AVE. Lexington,  MA  02173
Product CodeMQM  
CFR Regulation Number862.1113 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-02-19
Decision Date1998-05-06
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.